Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial — Otávio Berwanger (2022) | RDL Network
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial
Article 2022 en
Authors
OB
Otávio Berwanger
MP
Marc A. Pfeffer
BC
Brian Claggett
Abstract
1 min read
In this post-hoc analysis of the PARADISE-MI trial using the win ratio and including investigator-identified events not having CEC confirmation, sacubitril/valsartan was superior to ramipril among high-risk survivors of acute myocardial infarction.
M Schou, B Claggett, A Fernandez, G. Filippatos, Claire Granger, Karola Jering, Aldo Maggioni, Finnian R. McCausland, Joëlle Rouleau, F G Mody, Peter van der Meer, Dragoş Vinereanu, Y Zhou, Lars Køber
Marc A. Pfeffer, Brian Claggett, Eldrin F. Lewis, Christopher B. Granger, Lars Køber, Aldo Maggioni, Douglas L. Mann, John J.V. McMurray, Jean‐Lucien Rouleau, Scott D. Solomon, Philippe Gabríel Steg, Otávio Berwanger, Maja Čikeš, Carmine G. De Pasquale, Alberto Fernández, Gerasimos Filippatos, Karola Jering, Ulf Landmesser, Venugopal Menon, Béla Merkely, Mark C. Petrie, Ivo Petrov, Morten Schou, Michele Senni, David Sim, Peter van der Meer, Martin Lefkowitz, Yinong Zhou, Yi Wang, Eugene Braunwald
Mark C. Petrie, Scott Solomon, Brian Claggett, Karola Jering, Philippe Gabríel Steg, C. B. Granger, Eleanor T. Lewis, Lars Køber, Dougla L. Mann, Joëlle Rouleau, John J.V. McMurray, Aldo Maggioni, Eugene Braunwald, Michael Pfeffer
Karola Jering, Brian Claggett, Scott D. Solomon, Christopher B. Granger, Lars Køber, Ulf Landmesser, Eldrin F. Lewis, Aldo Maggioni, John J.V. McMurray, Béla Merkely, Grzegorz Opolski, Jean-Lucien Rouleau, Michele Senni, Marc A. Pfeffer
Karola Jering, B Claggett, Michael Pfeffer, Claire Granger, Lars Køber, Eldrin F. Lewis, Aldo Maggioni, Douglas L. Mann, John J.V. McMurray, M F Prescott, Joëlle Rouleau, Scott D. Solomon, Philippe Gabríel Steg, Dirk von Lewinski, Eugene Braunwald
Discussion(0)
No comments yet. Be the first to comment.